Innate and adaptive immune response to apoptotic cells

Journal of Autoimmunity

Volumn 29, Issue 4, 2007, Pages 303-309

  Peng, YuFeng ^a   Martin, David A ^a   Kenkel, Justin ^a   Zhang, Kang ^a   Ogden, Carol Anne ^a   Elkon, Keith B ^a  

^a Division of Rheumatology   (United States)

Author keywords

Anergy; Apoptosis; Dendritic cells; Macrophages; Tolerance

Indexed keywords

ANTIGEN; AUTOANTIBODY; CELL PROTEIN; METHOXSALEN; NUCLEIC ACID; OPSONIN; TOLL LIKE RECEPTOR; URIC ACID;

ADAPTIVE IMMUNITY; APOPTOSIS; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL FATE; CELL SURFACE; CELL TRANSPORT; CLONAL ANERGY; DENDRITIC CELL; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MACROPHAGE; MOLECULAR RECOGNITION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHAGOCYTE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PSORIASIS; PUVA; REGULATORY T LYMPHOCYTE; REVIEW; STIMULATION; T LYMPHOCYTE;

ANIMALS; APOPTOSIS; AUTOANTIGENS; HUMANS; IMMUNE TOLERANCE; IMMUNITY, NATURAL; MODELS, IMMUNOLOGICAL;

EID: 35448938105     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.07.017     Document Type: Review

References (67)

1. Abbas A.K., Lohr J., and Knoechel B. Balancing autoaggressive and protective T cell responses. J Autoimmun 28 (2007) 59-61
2. Blank M., and Shoenfeld Y. B cell targeted therapy in autoimmunity. J Autoimmun 28 (2007) 62-68
3. O'Brien B.A., Geng X., Orteu C.H., Huang Y., Ghoreishi M., Zhang Y., et al. A deficiency in the in vivo clearance of apoptotic cells is a feature of the NOD mouse. J Autoimmun 26 (2006) 104-115
4. Greenberg M.E., Sun M., Zhang R., Febbraio M., Silverstein R., and Hazen S.L. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med 203 (2006) 2613-2625
5. Kim S.J., Gershov D., Ma X., Brot N., and Elkon K.B. I-PLA(2) activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J Exp Med 196 (2002) 655-665
6. Gershov D., Kim S., Brot N., and Elkon K.B. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an anti-inflammatory innate immune response. Implications for systemic autoimmunity. J Exp Med 192 (2000) 1353-1364
7. Kim G., Jun J.B., and Elkon K.B. Necessary role of phosphatidylinositol 3-kinase in transforming growth factor beta-mediated activation of Akt in normal and rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 46 (2002) 1504-1511
8. Shaw P.X., Goodyear C.S., Chang M.K., Witztum J.L., and Silverman G.J. The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-associated neo-antigens and apoptotic cells. J Immunol 170 (2003) 6151-6157
9. Kearney J.F. Immune recognition of OxLDL in atherosclerosis. J Clin Invest 105 (2000) 1683-1685
10. Hayakawa K., and Hardy R.R. Development and function of B-1 cells. Curr Opin Immunol 12 (2000) 346-353
11. Grandien A., Coutinho A., Viale A.C., Freitas A., Andersson J., and Marcos M. On the origin of natural IgM in immunoglobulin transgenic mice. Intl Immunol 4 (1992) 1153-1160
12. Hayakawa K., Asano M., Shinton S.A., Gui M., Allman D., Stewart C.L., et al. Positive selection of natural autoreactive B cells. Science 285 (1999) 113-116
13. Martin F., and Kearney J.F. Marginal-zone B cells. Nat Rev Immunol 2 (2002) 323-335
14. Ogden C.A., Kowalewski R., Peng Y.F., Montenegro V., and Elkon K.B. IgM is required for efficient complement mediated phagocytosis of apoptotic cells in vivo. Autoimmunity 38 (2005) 259-264
15. Morelli A.E., Larregina A.T., Shufesky W.J., Zahorchak A.F., Logar A.J., Papworth G.D., et al. Internalization of circulating apoptotic cells by splenic marginal zone dendritic cells: dependence on complement receptors and effect on cytokine production. Blood 101 (2003) 611-620
16. Ren Y., Silverstein R.L., Allen J., and Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 181 (1995) 1857-1862
17. Stuart L.M., Henson P.M., and Vandivier R.W. Collectins: opsonins for apoptotic cells and regulators of inflammation. Curr Dir Autoimmun 9 (2006) 143-161
18. Gardai S.J., McPhillips K.A., Frasch S.C., Janssen W.J., Starefeldt A., Murphy-Ullrich J.E., et al. Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 123 (2005) 321-334
19. Hanayama R., Tanaka M., Miyasaka K., Aozasa K., Koike M., Uchiyama Y., et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304 (2004) 1147-1150
20. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19 (1998) 56-59
21. Albert M.L., Pearce S.F.A., Francisco L.M., Sauter B., Roy P., Silverstein R.L., et al. Immature dendritic cells phagocytose apoptotic cells via alpha-v-beta-5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med 188 (1998) 1359-1368
22. Mevorach D., Mascarenhas J., Gershov D.A., and Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med 188 (1998) 2313-2320
23. Luciani M.-F., and Chimini G. The ATP binding cassette transporter, ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J 15 (1996) 226-235
24. Devitt A., Moffatt O.D., Raykundalia C., Capra J.D., Simmons D.L., and Gregory C.D. Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392 (1998) 505-509
25. Lu Q., and Lemke G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293 (2001) 306-311
26. Somersan S., and Bhardwaj N. Tethering and tickling: a new role for the phosphatidylserine receptor. J Cell Biol 155 (2001) 501-504
27. Bellone M., Iezzi G., Rovere P., Galati G., Ronchetti A., Protti M.P., et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol 159 (1997) 5391-5399
28. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., and Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest 101 (1998) 890-898
29. Voll R.E., Herrmann M., Roth E.A., Stach C., Kalden J.R., and Girkontaite I. Immunosuppresive effects of apoptotic cells. Nature 390 (1997) 350-351
30. Huynh M.L., Fadok V.A., and Henson P.M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest 109 (2002) 41-50
31. Taylor P.R., Martinez-Pomares L., Stacey M., Lin H.H., Brown G.D., and Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 23 (2005) 901-944
32. Xu W., Roos A., Schlagwein N., Woltman A.M., Daha M.R., and van Kooten C. IL-10-producing macrophages preferentially clear early apoptotic cells. Blood 107 (2006) 4930-4937
33. Stuart L.M., Lucas M., Simpson C., Lamb J., Savill J., and Lacy-Hulbert A. Inhibitory effects of apoptotic cell ingestion upon endotoxin-driven myeloid dendritic cell maturation. J Immunol 168 (2002) 1627-1635
34. Kim S.J., Elkon K.B., and Ma X. Transcriptional suppression of interleukin-12 gene expression following phagocytosis of apoptotic cells. Immunity 21 (2004) 643-653
35. den Haan J.M., Lehar S.M., and Bevan M.J. CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med 192 (2000) 1685-1696
36. Belz G.T., Behrens G.M., Smith C.M., Miller J.F., Jones C., Lejon K., et al. The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med 196 (2002) 1099-1104
37. Schnorrer P., Behrens G.M., Wilson N.S., Pooley J.L., Smith C.M., El-Sukkari D., et al. The dominant role of CD8+ dendritic cells in cross-presentation is not dictated by antigen capture. Proc Natl Acad Sci U S A 103 (2006) 10729-10734
38. Albert M.L., Sauter B., and Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 392 (1998) 86-89
39. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440 (2006) 808-812
40. Kurts C., Carbone F.R., Barnden M., Blanas E., Allison J., Heath W.R., et al. CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med 186 (1997) 2057-2062
41. Naik S.H., Metcalf D., van Nieuwenhuijze A., Wicks I., Wu L., O'Keeffe M., et al. Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes. Nat Immunol 7 (2006) 663-671
42. Haring J.S., Badovinac V.P., and Harty J.T. Inflaming the CD8+ T cell response. Immunity 25 (2006) 19-29
43. Sporri R., and Reis e Sousa C. Inflammatory mediators are insufficient for full dendritic cell activation and promote expansion of CD4+ T cell populations lacking helper function. Nat Immunol 6 (2005) 163-170
44. Liu K., Iyoda T., Saternus M., Kimura Y., Inaba K., and Steinman R.M. Immune tolerance after delivery of dying cells to dendritic cells in situ. J Exp Med 196 (2002) 1091-1097
45. Sakaguchi S., Ono M., Setoguchi R., Yagi H., Hori S., Fehervari Z., et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212 (2006) 8-27
46. Maeda A., Schwarz A., Kernebeck K., Gross N., Aragane Y., Peritt D., et al. Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 174 (2005) 5968-5976
47. Kleinclauss F., Perruche S., Masson E., de Carvalho Bittencourt M., Biichle S., Remy-Martin J.P., et al. Intravenous apoptotic spleen cell infusion induces a TGF-beta-dependent regulatory T-cell expansion. Cell Death Differ 13 (2006) 41-52
48. Gallucci S., Lolkema M., and Matzinger P. Natural adjuvants: endogenous activators of dendritic cells. Nat Med 5 (1999) 1249-1255
49. Kawane K., Ohtani M., Miwa K., Kizawa T., Kanbara Y., Yoshioka Y., et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006) 998-1002
50. Rice G., Newman W.G., Dean J., Patrick T., Parmar R., Flintoff K., et al. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome. Am J Hum Genet 80 (2007) 811-815
51. Martin D.A., and Elkon K.B. Apoptosis. In: Hahn B.H. (Ed) (2007), Dubois' Lupus
52. Ishii K.J., and Akira S. Innate immune recognition of, and regulation by, DNA. Trends Immunol 27 (2006) 525-532
53. Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 8 (2007) 487-496
54. Zhou Z.-H., Tzioufas A.G., and Notkins A.L. Properties and function of polyreactive antibodies and polyreactive antigen-binding B cells. J Autoimmun 29 (2007) 219-228
55. Ruiz-Argüelles A., Brito G.J., Reyes-Izquierdo P., Pérez-Romano B., and Sánchez-Sosa S. Apoptosis of melanocytes in vitiligo results from antibody penetration. J Autoimmun 29 (2007) 281-286
56. Zelenay S., Fontes M.F.M., Fesel C., Demengeot J., and Coutinho A. Physiopathology of natural auto-antibodies: the case for regulation. J Autoimmun 29 (2007) 229-235
57. Papadimitraki E.D., Bertsias G., and Boumpas D.T. Toll like receptors and autoimmunity: a critical appraisal. J Autoimmun 29 (2007) 310-318
58. Lutz H.U. Homeostatic roles of naturally occurring antibodies. An overview. J Autoimmun 29 (2007) 287-294
59. Cohen I.R. Biomarkers, self-antigens and the immunological homunculus. J Autoimmun 29 (2007) 246-249
60. Pasquali J.-L., Soulas-Sprauel P., Korganow A.-S., and Martin T. Auto-reactive B cells in transgenic mice. J Autoimmun 29 (2007) 250-256
61. Lang K.S., Burow A., Kurrer M., Lang P., and Recher M.J. The role of the innate immune response in autoimmune disease. J. Autoimmun 29 (2007) 206-212
62. Vollmers H.P., and Brändlein S. Natural antibodies and cancer. J Autoimmun 29 (2007) 295-302
63. Rowley B., Tang L., Shinton S., Hayakawa K., and Hardy R.R. Autoreactive B-1 B cells: constraints on natural autoantibody B cell antigen receptors. J Autoimmun 29 (2007) 236-245
64. Ryan K.R., Patel S.D., Stephens L.A., and Anderton S.M. Death, adaptation and regulation: the three pillars of immune tolerance restrict the risk of autoimmune disease caused by molecular mimicry. J Autoimmun 29 (2007) 262-271
65. Avrameas S., Ternynck T., Tsonis I.A., and Lymperi P. Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 29 (2007) 213-218
66. Milner J., Ward J., Keane-Myers A., Min B., and Paul W.E. Repertoire-dependent immunopathology. J. Autoimmun 29 (2007) 257-261
67. Lan R.Y., Mackay I.R., and Gershwin M.E. Regulatory T cells in the prevention of mucosal inflammatory diseases: patrolling the border. J Autoimmun 29 (2007) 272-280